Affiliation:
1. Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China
Abstract
The outbreak of COVID-19 due to SARS-CoV-2 originally emerged in Wuhan in
December 2019. As of March 22, 2020, the disease spread to 186 countries, with at least 305,275
confirmed cases. Although there has been a decline in the spread of the disease in China, the prevalence
of COVID-19 around the world remains serious despite containment efforts undertaken by national
authorities and the international community. In this article, we systematically review the brief
history of COVID-19 and its epidemic and clinical characteristics, highlighting the strategies used to
control and prevent the disease in China, which may help other countries respond to the outbreak.
This pandemic emphasizes the need to be constantly alert to shifts in both the global dynamics and
the contexts of individual countries, making sure that all are aware of which approaches are successful
for the prevention, containment and treatment of new diseases, and being flexible enough to
adapt the responses accordingly.
Funder
Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University
Shanghai Pujiang Program
Program for Young Eastern Scholars at Shanghai Institutions of Higher Learning
Major Science and Technology Innovation Program of Shanghai Municipal Education Commission
Key Research Program of the Chinese Academy of Sciences
National Natural Science Foundation
National Key R&D Program of China
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Drug Discovery,Pharmacology,Oncology
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献